Correlation Between Cingulate Warrants and Tempest Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cingulate Warrants and Tempest Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cingulate Warrants and Tempest Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cingulate Warrants and Tempest Therapeutics, you can compare the effects of market volatilities on Cingulate Warrants and Tempest Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cingulate Warrants with a short position of Tempest Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cingulate Warrants and Tempest Therapeutics.
Diversification Opportunities for Cingulate Warrants and Tempest Therapeutics
0.53 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Cingulate and Tempest is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding Cingulate Warrants and Tempest Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tempest Therapeutics and Cingulate Warrants is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cingulate Warrants are associated (or correlated) with Tempest Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tempest Therapeutics has no effect on the direction of Cingulate Warrants i.e., Cingulate Warrants and Tempest Therapeutics go up and down completely randomly.
Pair Corralation between Cingulate Warrants and Tempest Therapeutics
Assuming the 90 days horizon Cingulate Warrants is expected to generate 5.73 times more return on investment than Tempest Therapeutics. However, Cingulate Warrants is 5.73 times more volatile than Tempest Therapeutics. It trades about 0.09 of its potential returns per unit of risk. Tempest Therapeutics is currently generating about -0.03 per unit of risk. If you would invest 5.13 in Cingulate Warrants on December 30, 2024 and sell it today you would earn a total of 0.08 from holding Cingulate Warrants or generate 1.56% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 96.77% |
Values | Daily Returns |
Cingulate Warrants vs. Tempest Therapeutics
Performance |
Timeline |
Cingulate Warrants |
Tempest Therapeutics |
Cingulate Warrants and Tempest Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Cingulate Warrants and Tempest Therapeutics
The main advantage of trading using opposite Cingulate Warrants and Tempest Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cingulate Warrants position performs unexpectedly, Tempest Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tempest Therapeutics will offset losses from the drop in Tempest Therapeutics' long position.Cingulate Warrants vs. Cingulate | Cingulate Warrants vs. Celularity | Cingulate Warrants vs. NeuroSense Therapeutics Ltd | Cingulate Warrants vs. Dermata Therapeutics Warrant |
Tempest Therapeutics vs. Indaptus Therapeutics | Tempest Therapeutics vs. Rezolute | Tempest Therapeutics vs. Forte Biosciences | Tempest Therapeutics vs. Sana Biotechnology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Bonds Directory Find actively traded corporate debentures issued by US companies |